{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:52:27Z","timestamp":1769507547587,"version":"3.49.0"},"reference-count":5,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2023.2023.0368","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T06:21:02Z","timestamp":1709533262000},"page":"57-58","source":"Crossref","is-referenced-by-count":2,"title":["Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia"],"prefix":"10.4274","author":[{"given":"Ay\u015fe","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim","family":"Aras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pervin","family":"\u00d6zkan Kurtg\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut","family":"\u00c7ak\u0131ro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bjh.14302","article-title":"Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management","volume":"180","author":"Iberri","year":"2016","unstructured":"1. Iberri DJ, Kwong BY, Stevens LA, Coutre SE, Kim J, Sabile JM, Advani RH. Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management. Br J Haematol 2016;180:164-166.","journal-title":"Br J Haematol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jaad.2019.12.031","article-title":"Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse events","volume":"88","author":"Singer","year":"2023","unstructured":"2. Singer S, Tan SY, Dewan AK, Davids M, LaCasce AS, Treon SP, LeBoeuf NR. Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse events. J Am Acad Dermatol 2023;88:1271-1281.","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Pileri A, Guglielmo A, Agostinelli C, Evangelista V, Bertuzzi C, Alessandrini A, Bruni F, Starace M, Massi A, Broccoli A, Patrizi A, Zinzani PL, Piraccini BM. Cutaneous adverse\u2010events in patients treated with ibrutinib. Dermatol Ther 2020;33:e14190.","DOI":"10.1111\/dth.14190"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4274\/tjh.galenos.2020.2020.0120","article-title":"Ibrutinib-induced skin rash","volume":"38","author":"Kirar","year":"2021","unstructured":"4. Kirar S, Gogia A, Gupta R, Mallick S. Ibrutinib-induced skin rash. Turk J Hematol 2021;38:81.","journal-title":"Turk J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ajh.23775","article-title":"Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia","volume":"90","author":"Mannis","year":"2015","unstructured":"5. Mannis G, Wu D, Dea T, Mauro T, Hsu G. Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia. Am J Hematol 2015;90:179.","journal-title":"Am J Hematol"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T08:10:16Z","timestamp":1710490216000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-73468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":5,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2023.2023.0368","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]}}}